AGILENT TECHNOLOGIES INC

A stock represents a share of ownership in Agilent Technologies, a company that provides analytical instruments, software, and services for laboratories and research. Buying A makes an investor a partial owner of the business, with claims on its future earnings and assets. The shares trade on the New York Stock Exchange under the ticker A.

Recent performance for A depends on changing market conditions, so check the latest price chart and daily change shown on this page. Historical returns can be reviewed across multiple periods. Analysts often compare A's move with the broader market and with peers in life sciences tools and diagnostics to assess relative strength. The page displays up-to-date data.

Valuation for A can be assessed using several metrics, including the price-to-earnings ratio, price-to-sales ratio, and enterprise value relative to EBITDA or free cash flow. Comparing these ratios with A's own history and with industry peers helps gauge whether the market is pricing in high or low expectations. Growth rates and margins also matter when interpreting multiples.

Yes, A may be traded in pre-market and after-hours sessions through many brokers, though liquidity is typically lower and spreads wider than during regular hours. Extended-hours trading carries additional risks, such as greater price volatility and limited order types. Investors should confirm availability and any fees with their brokerage before placing orders outside standard NYSE hours.

Agilent Technologies has a history of returning cash to shareholders through dividends, though the exact amount and frequency can change over time. Check this page for the latest declared dividend, yield, and payment schedule. Dividend policy depends on earnings, cash flow, and board decisions. Investors often review payout ratios and dividend growth trends when evaluating income potential.

Risks for A include exposure to economic cycles affecting laboratory and healthcare spending, competitive pressure from other analytical instrument makers, foreign currency fluctuations, and regulatory or geopolitical changes in key markets. A's performance is also tied to demand in pharmaceuticals, diagnostics, and academic research. These and other factors can influence revenue, margins, and the stock price.